$Generation Bio (GBIO.US)$ NEWS Generation Bio Announces the...
NEWS
Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
Generation Bio Co. will present six abstracts at the ASGCT 27th Annual Meeting.
The abstracts will highlight preclinical data from the company's ctLNP and iqDNA platforms.
One of the presentations will focus on highly specific, in vivo delivery to T-cells with cell-targeted lipid nanoparticles.
The company is excited to showcase its technical advancements and breakthroughs at the event.
The ASGCT abstracts are available to the public online.
Presentation materials will be uploaded to the company's website on the day of each presentation.
The abstracts will highlight preclinical data from the company's ctLNP and iqDNA platforms.
One of the presentations will focus on highly specific, in vivo delivery to T-cells with cell-targeted lipid nanoparticles.
The company is excited to showcase its technical advancements and breakthroughs at the event.
The ASGCT abstracts are available to the public online.
Presentation materials will be uploaded to the company's website on the day of each presentation.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment